Martine A Rothblatt

Chairperson & CEO · United Therapeutics

Martine A Rothblatt (Chairperson & CEO) filed 187 Form 4 reports in the trailing twelve months (0 purchases, 187 sales, 1 filed past the two-business-day deadline), most often in United Therapeutics Corporation (UTHR). The largest single filing was $10.9M of UTHR (18,840 sh across 15 lots, as filed), executed Apr 14. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

187

0 buys · 187 sells · 1 late

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$889.0M

shares × price, as filed

Last traded

Nov 5

Filed Nov 6

Median ADV $265.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $989.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 187 filings

Sector per market data · by filing · past 12 months

Most traded names

UTHR

United Therapeutics Corporation UTHR · 0 buys · 210 sells 210 filings

Recent filings

UTHRSALE United Therapeutics Corporation View filing → $946K
1,583 sh across 5 lots
Exec Nov 5
Filed Nov 6 · 4:57 PM ET UTHRSALE United Therapeutics Corporation View filing → $3.9M
6,744 sh across 17 lots
Exec Nov 5
Filed Nov 6 · 4:54 PM ET UTHRSALE United Therapeutics Corporation View filing → $1.0M
1,643 sh across 3 lots
Exec Nov 4
Filed Nov 5 · 5:21 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.1M
6,792 sh across 14 lots
Exec Nov 4
Filed Nov 5 · 5:21 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.6M
9,380 sh across 7 lots
Exec Nov 3
Filed Nov 4 · 4:38 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.7M
9,500 sh across 7 lots
Exec Nov 2
Filed Nov 3 · 4:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.5M
9,221 sh across 9 lots
Exec Oct 30
Filed Nov 2 · 4:34 PM ET UTHRSALE United Therapeutics Corporation View filing → $5.6M
9,407 sh across 7 lots
Exec Oct 29
Filed Oct 30 · 4:30 PM ET More filings →